CRT - Antibody Catalogue

Working With CRT

Testimonials

Licensing Portfolio

Small Molecules

Biological Therapeutics

Mouse & Cell Line Portfolio

CRT's Discovery Pipeline

Commercialisation Routes

Antibody Portfolio - A

Antigen	Clone
ACK (drosophila)	ACK 1F4/9
Activin receptor- type 2 (ACTR2)	149/1
ADA protein	ADA-1
Adenomatous Polyposis Coli (APC)	ALi 12-28
ADP-Ribosylation Factor 1(ARF1)	ARFS 1A9/5
ADP-Ribosylation Factor 1(ARF1)	ARFS 3F1
ADP-Ribosylation Factor 1(ARF1)	ARFS 5F2/2
Adrenomedullin	HTA171/E8
Adrenomedullin	HTA91a/G2
AF10	HAF10 10D3/8
AF10	HAF10 9A5/2
Alkaline phosphatase (calf intestine)	AP1B9
Alkaline Phosphatase (calf intestine)	AP-7/6/7
Alkaline phosphatase (human intestinal)	AAP1
Anaphase-promoting complex subunit 5 (APC5)	APC5#4
Annexin I	ANEX 5E4/1
Annexin I	ANEX 6E4/3
Annexin II	ANEX 3D5/4
AP-2 α and β forms.	A6/2/2
AP-2α	AP2a 8G8/5
AP-2β	AP2b 1F3/8
AP-2β	AP2b 1G6/2
AP-2γ	AP2g 6E4/4
APC11	AX2.1
Aprataxin	Polyclonal
Asf1	ASF 4A1/3
ATF1 Yeast transcription factor	ATF1 2A9/8
ATG9	14F2 8B1
ATMIN	11F4
Ataxia telangiesctasia mutated (ATM) protein	ATM 11G12

For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information.